A novel diarylheptanoid known as compound 28 holds promise as a potential therapeutic candidate for sepsis treatment by exhibiting agonistic properties toward the α7 nAchR-JAK2-STAT3 signaling pathway (133). This evidence concerns the gene CHRNA7 and Sepsis.